Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Skinvisible, Inc. (SKVI), Quoin Pharmaceuticals Proposed Merger to Address Opioid Pain Management Market

A merger between Skinvisible and Quoin will enable a successful entry on the post-surgical pain management market Opioids – which typically refer to oxycodone, hydrocodone, and fentanyl – are highly addictive painkillers; nearly three in 10 Americans prescribed opioids for chronic pain will abuse them Opioids are becoming increasingly deadly to Americans; in 2016, two-thirds […]

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Developing Alternative Solutions in Health-Boosting Market

Company offers options to patients seeking immune system-boosting alternatives Novel “scorpion venom” product builds on popular Cuban cancer-fighting therapy Developing a CBD-based nose-to-brain delivery system that will provide relief across a range of indications from pain, inflammation, seizures and neurological disorders In an era when a licensed and regulated medical industry provides a secure standard […]

Riot Blockchain, Inc. (NASDAQ: RIOT) Investments Solidify Effort to Build Decentralized Tech Platforms

Company’s investments in Verady, Coinsquare and TessPay among recent work to increase security for transactions Blockchain, cannabis sectors accounted for nearly 10 percent of rising daily activity for TD Ameritrade in 4Q2017 Estimated $10 billion in cryptocurrency transacted each day Riot Blockchain, Inc. (NASDAQ: RIOT) is advancing its focus on the rising blockchain technology and […]

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Agreement with Cannabis-Infused Edibles Manufacturer

Lexaria enters agreement with Cannfections to develop an innovative range of cannabis-infused chocolates and gummies incorporating its proprietary technology, DehydraTECH™ Cannfection’s formulation and manufacturing expertise can be offered to other Lexaria licensee partners The agreement is expected to generate new cannabis-based edible products for domestic and international markets On January 25, 2018, Lexaria Bioscience Corp. […]

Sunniva, Inc. (CSE: SNN) Begins Trading on the Canadian Stock Exchange

SNN is a vertically integrated medial cannabis company operating in California and Canada Company’s goal is to increase shareholder value by boosting stock liquidity and increasing exposure to investors SNN has a number of subsidiaries, including Sunniva Medical, Inc., CP Logistics, LLC, Natural Health Services Ltd., and Full Scale Distributors, LLC Sunniva, Inc., (CSE: SNN) […]

Pivot Pharmaceuticals Inc. (PVOTF) is “One to Watch”

Transdermal cannabis-based therapy promises greater absorption, less side effects Global medical marijuana market projected to reach $55.8 billion U.S. by 2025 Novel CBD delivery method targets array of unmet healthcare needs Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals […]

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Teams with UniQuest to Develop Novel Cannabinoid Delivery System

Global nasal drug delivery technology market expected to reach $64 billion by 2021 Development of CBD-infused soluble gel for nasal delivery targets range of diseases Clinical benefits of Sol-gel delivery method include a safer, more reliable delivery platform with higher efficacy Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and UniQuest […]

 

From Our Blog

Heartbeam Inc. (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation

March 24, 2026

HeartBeam (NASDAQ: BEAT) recently announced a collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology, marking another step in the company’s push to expand its role in next-generation cardiac monitoring. The announcement highlights HeartBeam’s growing focus on artificial intelligence (“AI”)-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward […]

Rotate your device 90° to view site.